The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global anesthesia and respiratory devices market size reached US$ 40.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 62.3 Billion by 2027, exhibiting a growth rate (CAGR) of 7.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Anesthesia and respiratory devices aid in enhancing the care of patients suffering from acute and chronic respiratory diseases. They also assist in improving the performance of diagnostic, therapeutic, and monitoring functions. They comprise dosing units, respiratory devices, and monitoring equipment. They facilitate automatic adjustment of inhalation and exhalation as per the requirement of patient. As a result, anesthesia and respiratory devices are utilized in hospitals, clinics, home care settings, and ambulatory and dialysis centers.
The increasing prevalence of respiratory disorders and other ailments, such as chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis, among the masses represents one of the major factors positively influencing the demand for anesthesia and respiratory devices worldwide. It can also be attributed to the rising geriatric population, which is more susceptible to these medical conditions. In addition, the growing incidences of airborne diseases and the increasing air pollution levels are contributing to the market growth. It can also be accredited to the growing number of smokers and alcohol consumption due to hectic lifestyles. Moreover, the rising number of fatal road accidents is resulting in severe injuries, which is catalyzing the demand for anesthesia and respiratory devices across the globe. Apart from this, there is an increase in the uptake of health insurance policies that provide financial assistance for various medical treatments to minimize healthcare expenses. Along with this, the growing preference for minimally invasive (MI) surgical procedures among patients and healthcare professionals is creating a positive outlook for the market. Furthermore, significant improvements in the healthcare infrastructure, improved diagnostic technologies, and research and development (R&D) activities by key players for introducing novel devices are anticipated to offer lucrative growth opportunities to industry investors.
IMARC Group provides an analysis of the key trends in each sub-segment of the global anesthesia and respiratory devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and end user.
Breakup by Product Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Becton, Dickinson and Company, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, GE HealthCare (General Electric), Getinge AB, Hamilton Medical (Hamilton Bonaduz AG), ICU Medical Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, SunMed LLC and Teleflex Incorporated.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, Becton, Dickinson and Company, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, GE HealthCare (General Electric), Getinge AB, Hamilton Medical (Hamilton Bonaduz AG), ICU Medical Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, SunMed LLC and Teleflex Incorporated.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at